SCHEMBL12419334

SCHEMBL12419334

CB(C)c1ccc(Cc2nccs2)cc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.46
ADRB2 P07550 1/20 0.39
LOXL2 Q9Y4K0 1/20 0.35
SLC6A3 Q01959 3/20 0.34
NR1H3 Q13133 1/20 0.33
CYP17A1 P05093 1/20 0.33
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
FDPS P14324 1/20 0.33
PDPK1 O15530 1/20 0.32
ALDH1A1 P00352 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
CYP2C19 P33261 1/20 0.31
ACACB O00763 1/20 0.31
KDM1A O60341 1/20 0.31
MAOB P27338 1/20 0.31
TRPM8 Q7Z2W7 1/20 0.30
KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27855068 0.77 CYP2C19 (0.50) LTA4HADRB2LOXL2CYP17A1CYP11B1
SCHEMBL6821892 0.77 LTA4H (0.49) LTA4HADRB2LOXL2NR1H3CYP17A1
SCHEMBL27468396 0.77 NR1H3 (0.51) LTA4HADRB2LOXL2SLC6A3NR1H3
SCHEMBL2973461 0.77 LTA4H (0.49) LTA4HADRB2LOXL2ALDH1A1GAA
SCHEMBL558329 0.76 LTA4H (0.56) LTA4HALDH1A1GAAMAPTCYP2C19
SCHEMBL378027 0.76 PDPK1 (0.50) LTA4HSLC6A3NR1H3PDPK1ALDH1A1
SCHEMBL6163997 0.76 CYP17A1 (0.50) LTA4HADRB2LOXL2SLC6A3NR1H3
SCHEMBL5533749 0.75 LOXL2 (0.62) LTA4HADRB2LOXL2SLC6A3CYP17A1
SCHEMBL7617248 0.74 PDPK1 (0.48) LTA4HSLC6A3NR1H3PDPK1ALDH1A1
Hydrochloric Acid SCHEMBL3930720 0.74 PDPK1 (0.48) LTA4HSLC6A3NR1H3PDPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150368278-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. (US) 2015-12-24 US disclosed
US-8957049-B2 Inhibitors of fatty acid amide hydrolase INFINITY PHARMACEUTICALS, INC. (US) 2015-02-17 US disclosed
US-20110172186-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. 2011-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172186-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, ASAH1 LTA4H 6/4885ADRB2 1016/4885LOXL2 1401/4885
US-20150368278-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, ASAH1 LTA4H 6/4885ADRB2 1016/4885LOXL2 1401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.